General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements Of Cash Flow

v3.21.2
Consolidated Statements Of Cash Flow - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities        
Net loss $ (106,511) $ (52,237) $ (114,164) $ (110,349)
Reconciliation of net loss to net cash used in operating activities:        
Depreciation and amortization expense 7,295 3,255 7,404 3,985
Non-cash interest expense, and amortization of debt discount and issuance costs 1,789 0    
Non-cash interest expense related to convertible notes       22,823
Loss from change in the fair value of derivative liabilities       4,947
Convertible note extinguishment loss       366
Stock-based compensation expense 11,800 2,665 7,185 3,906
Other non-cash compensation expense 3,747      
Write-off of in-process research and development project 5,030      
Income from equity method investment (8,891) 0 (5,799)  
Net increase in equity method investment (2,107)      
Gain on deconsolidation of subsidiary     (6,904)  
Net accretion and amortization of investments in marketable securities 2,530 (508) 1,179  
Changes in operating assets and liabilities        
Other receivables (1,682) (263) (4,524) (58)
Prepaid expenses and other current assets (1,052) (370) 1,423 (4,215)
Other non-current assets (124) (46) (82) (68)
Accounts payable 84 (489) 3,260 1,204
Accrued expenses and other current liabilities 1,808 153 5,332 625
Deferred rent (140) (98) (210) 597
Net cash used in operating activities (77,533) (47,938) (105,900) (76,237)
Cash flows from investing activities        
Purchase of marketable securities (289,092) (456,964)    
Purchase of marketable debt securities     (620,781)  
Proceeds from sales of marketable debt securities     28,660  
Proceeds from sales of marketable securities 40,227      
Proceeds from maturities of marketable securities 239,415 60,975 222,675  
Purchases of property and equipment (14,509) (13,546) (23,306) (9,240)
Disposal of cash on deconsolidation upon loss of control over the fully owned subsidiary     (407)  
Asset acquisition (4,981)      
Net cash used in investing activities (28,940) (409,535) (393,159) (9,240)
Cash flows from financing activities        
Proceeds from issuance of Series C redeemable convertible preferred stock, net   69,860 69,860 454,260
Proceeds from issuance of notes payable   2,708    
Proceeds from issuance of convertible notes payable 74,972     12,267
Proceeds from exercise of stock options and stock purchase rights 552 59 369 1,376
Proceeds from tenant improvement loan       1,056
Repayments of tenant improvement loan (119) (266) (383)  
Proceeds from issuance common stock warrants 120      
Payments on capital lease obligation (435) (361) (626) (549)
Payments for deferred offering costs (1,621)      
Net cash provided by financing activities 73,469 72,000 69,220 468,410
Net change in cash, cash equivalents and restricted cash (33,004) (385,473) (429,839) 382,933
Cash, cash equivalents and restricted cash, at the beginning of the year 78,030 507,869 507,869 124,936
Cash, cash equivalents and restricted cash, at the end of the year 45,026 122,396 78,030 507,869
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets        
Cash and cash equivalents 44,264 121,703 77,337 507,176
Restricted cash 762 693 693 693
Cash, cash equivalents and restricted cash in consolidated balance sheets 45,026 122,396 78,030 507,869
Unpaid property and equipment purchases 1,011 $ 725 1,806 4,112
Property and equipment purchased through capital leases 926     1,332
Deconsolidation of net liabilities of fully owned subsidiary due to loss of control     $ 1,713  
Uber Elevate acquisition in exchange for Series C redeemable convertible preferred stock (Note 4) $ 77,619      
Conversion of convertible notes into redeemable convertible preferred stock       80,793
Settlement of derivative liabilities upon conversion of convertible notes into redeemable convertible preferred stock       $ 36,084